The Tripeptide, GHK, Induces Programmed Cell Death in SH-SY5Y Neuroblastoma Cells
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
GHK-Cu is a tripeptide that is found in plasma and increases fibroblast proliferation and is widely used in wound healing creams. Studies show that GHK-Cu stimulates the level of p63, a member of the antitumor suppressor family which includes p53 and p73. Because of its effect on p63, we tested the hypothesis that GHK induces apoptosis in neuroblastoma cells, SH-SY5Y, and that modification of GHK by polyethylene glycol (PEG) conjugation, PEGylation, potentiates its effects. Initial studies on NIH-3T3 fibroblasts and U937 histiocytic lymphoma cells show that GHK-Cu and GHK-PEG stimulate fibroblast proliferation while attenuating U937 cell proliferation. SH-SY5Y cells were treated with GHK or GHK-PEG at 1 and 10 nM for 24 hours followed by cell proliferation, cell viability, cell cytotoxicity and apoptosis assays. Our results showed that 24 hour GHK treatment elevated apoptosis by 1.8 ± 0.17 and 3.3 ± 0.15 fold at 1 and 10 nM, respectively. GHK-PEG treatment, on the other hand, stimulated apoptosis by 3.2 ± 0.80 and 4.9 ± 0.9 fold at 1 and 10 nM, respectively. The treatments, while having no effects on cell cytotoxicity, reduced neuroblastoma cell viability and cell proliferation. Therefore, GHK induces apoptosis in neuroblastoma cells, an affect which was potentiated by PEGylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, GHK has been found to reset genes of diseased cells from patients with cancer or COPD to a more healthy state.”
From GHK and DNA: Resetting the human genome to health (2014) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When three lines of human cancer cells (SH-SY5Y neuroblastoma cells, U937 histolytic cells, breast cancer cells) were incubated in culture with 1 to 10 nanomolar GHK, the programmed cell death system (apoptosis) was reactivated and cell growth inhibited [9].”
From GHK and DNA: Resetting the human genome to health (2014) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Matalka et al. demonstrated that GHK, at 1 to 10 nM, inhibited the growth of human SH-SY5Y neuroblastoma cells and human U937 histiocytic lymphoma cells. It also re-activated the apoptosis system, as measured by the caspases 3 and 7. In contrast, GHK stimulated the growth of healthy human NIH-3T3 fibroblasts [48].”
From Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data (2018) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In contrast, both GHK and GHK-PEG increased the replication of NIH3T3 fibroblast cells [23].”
From Skin Regenerative and Anti-Cancer Actions of Copper Peptides (2018) · cites this paper as [23]
The cited source says what the claim attributes to it.
In the citing paper
“Matalka et al. demonstrated that GHK, at 1 to 10 nanomolar, reactivated the apoptosis system, as measured by caspases 3 and 7”
From GHK and DNA: Resetting the human genome to health (2014) · cites this paper as [9]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
The Connectivity Map: A new tool for biomedical research
Lamb, J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2044 · Cited by 945 · cited 1×
“The diversity of its actions in human is attributed to its ability to modulate the expression of a number of genes [4].”
BackgroundMurray-Zmijewski, F., Lane, D. P., & Bourdon, J.-C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 523
Hong, Y., Downey, T., Eu, K. W., Koh, P. K., & Cheah, P. Y. (2010) · Clinical & Experimental Metastasis · doi:10.1007/s10585-010-9305-4 · Cited by 319 · cited 1×
“The potential role of this tripeptide in cancer therapeutics was demonstrated in studies which showed that GHK-Cu reversed the expression of certain genes involved in metastatic spread of colon cancer, even at very low concentrations [12].”
BackgroundPegylation: engineering improved pharmaceuticals for enhanced therapy
Molineux, G. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)80004-4 · Cited by 225
Maquart, F.-X., Pickart, L., Laurent, M., Gillery, P., Monboisse, J.-C., & Borel, J.-P. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80509-x · Cited by 181 · cited 1×
“Therefore in the late 1980’s, GHK-Cu began to gain wide use as a wound healing agent [5,6].”
BackgroundGrowth-modulating plasma tripeptide may function by facilitating copper uptake into cells
Pickart, L., Freedman, J. H., Loker, W. J., Peisach, J., Perkins, C. M., Stenkamp, R. E., & Weinstein, B. (1980) · Nature · doi:10.1038/288715a0 · Cited by 175
Wegrowski, Y., Maquart, F. X., & Borel, J. P. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90504-i · Cited by 72
4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line
Laurora, S., Tamagno, E., Briatore, F., Bardini, P., Pizzimenti, S., Toaldo, C., Reffo, P., Costelli, P., Dianzani, M. U., Danni, O., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.10.014 · Cited by 70
Control of fibrinogen biosynthesis: The role of free fatty acid
Pilgeram, L. O., & Pickart, L. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80089-4 · Cited by 63
Nahor, I., Abramovitch, S., Engeland, K., & Werner, H. (2005) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2005.07.005 · Cited by 56
Effect of PEGylation on the Stability of Liposomes During Nebulisation and in Lung Surfactant
Anabousi, S., Kleemann, E., Bakowsky, U., Kissel, T., Schmehl, T., Gessler, T., Seeger, W., Lehr, C.-M., & Ehrhardt, C. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.461 · Cited by 54
Mulder, G. D., Patt, L. M., Sanders, L., Rosenstock, J., Altman, M. I., Hanley, M. E., & Duncan, G. W. (1994) · Wound Repair and Regeneration · doi:10.1046/j.1524-475x.1994.20406.x · Cited by 53
Copper–GHK increases integrin expression and p63 positivity by keratinocytes
Kang, Y.-A., Choi, H.-R., Na, J.-I., Huh, C.-H., Kim, M.-J., Youn, S.-W., Kim, K.-H., & Park, K.-C. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0942-x · Cited by 51
PEGylation of Liposome Decreases the Susceptibility of Liposomal Drug in Cancer Photodynamic Therapy
Ichikawa, K., Hikita, T., Maeda, N., Takeuchi, Y., Namba, Y., & Oku, N. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.443 · Cited by 50
Gwosdz, C., Balz, V., Scheckenbach, K., & Bier, H. (2004) · KARGER eBooks · doi:10.1159/000082473 · Cited by 23
Baydar, D. E., Kulaç, İ., Gürel, B., & Marzo, A. D. (2010) · International Journal of Surgical Pathology · doi:10.1177/1066896910379478 · Cited by 17
Control of Fibrinogen Biosynthesis: Role of the FFA/Albumin Ratio
Pilgeram, L. O. (2010) · Cardiovascular Engineering An International Journal · doi:10.1007/s10558-010-9092-1 · Cited by 17
Cited by
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data
Pickart, L., & Margolina, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071987 · Cited by 158
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2015) · BioMed Research International · doi:10.1155/2015/648108 · Cited by 144
“culture with 1 to 10 nanomolar GHK, the programmed cell death system (apoptosis) was reactivated and cell growth inhibited [26].”
BackgroundGHK and DNA: Resetting the human genome to health
Pickart, L., Vasquez-Soltero, J. M., & Margolina, A. (2014) · BioMed Research International · doi:10.1155/2014/151479 · Cited by 39
Skin Regenerative and Anti-Cancer Actions of Copper Peptides
Pickart, L., & Margolina, A. (2018) · Cosmetics · doi:10.3390/cosmetics5020029 · Cited by 33
Lee, A.-R. C. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00438-y · Cited by 20
Metadata
- Authors
- E. Matalka, L.
- Venue
- Journal of Biotechnology & Biomaterials
- Publisher
- OMICS Publishing Group
- Published
- 2012
- Volume
- 02
- Issue
- 05
- ISSN
- 2155-952X (ISSN-L)
- OpenAlex
- W2137901468
- Semantic Scholar
- deeae64426252a3a41fac04afdee148f0637aa6e
- Cited by
- 12
- References
- 18
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 1 · 2019: 2 · 2018: 2 · 2016: 1 · 2015: 2 · 2014: 2
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Journal of Biotechnology & Biomaterials (publishedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Oncology › Neuroblastoma Research and Treatments
- Keywords
- GHK-Cu, tripeptides, apoptosis, neuroblastoma, SH-SY5Y cells, PEGylation, p63, anticancer peptides, cell proliferation, cell viability, cytotoxicity, U937 cells, NIH3T3 cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.